• 

  SII CEO Adar Poonawalla receives Covid-19 vaccine as nationwide vaccination drive begins

  India | January 16, 2021 14:34 IST

  As nationwide Covid-19 vaccination drive begins, Serum Institute of India (SII) CEO Adar Poonawalla on Saturday received Covid-19 vaccine - Covidshield in Pune.

• 

  India’s Covid-19 vaccine drive to kick off at 3,000 sites on Saturday | Watch Ground Report

  News | January 14, 2021 17:38 IST

  India's vaccination drive against Covid-19 will be launched at around 3,000 sites on January 16 and the number of sites will be ramped up to 5,000 by the end of the month.

• 

  COVID vaccine transport from Serum Institute of India to commence soon

  India | January 11, 2021 8:23 IST

  The Central government on Saturday said India will launch its COVID-19 vaccination drive from January 16, with priority to be given to nearly three crore health care and frontline workers.

• 

  Is it safe for cancer, diabetic patients to take COVID-19 vaccine? Details here

  India | January 04, 2021 10:50 IST

  The Serum Institute of India, the world's largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield, while Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

• 

  'Very safe': Serum Institute's Adar Poonawalla assures as Covishield gets approval

  India | January 03, 2021 19:55 IST

  Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla on Sunday assured that the Covishield vaccine, which has received approval for restricted emergency use, is "very safe".

• 

  Super 100 | Adar Poonawalla thanks PM Modi, DCGI after Covishield gets final approval

  News | January 03, 2021 16:28 IST

  Even before getting the approval from the apex drug controller of India, Serum Institute of India stockpiled about 40-50 million doses of the Covid-19 vaccine, taking a major risk.

• 

  'Absolute rubbish': DCGI on impotency rumours, says Covid vaccines 110% safe

  India | January 03, 2021 13:17 IST

  As India gears up for the world's largest vaccination programme, the Drugs Controller General of India (DCGI) on Sunday quelled rumours surrounding the COVID-19 vaccines regarding impotency, rubbishing such speculations as "absolute nonsense".

• 

  Vaccine of the BJP, won't take shot, says Akhilesh Yadav; faces flak

  India | January 02, 2021 23:24 IST

  Samajwadi Party president Akhilesh Yadav Saturday termed the COVID-19 vaccines to be rolled out in the country as "vaccine of the BJP" and said he would not take the shot, drawing a sharp retort from the ruling party which accused him of "insulting" the doctors and scientists.

• 

  No emergency approval for vaccine maker SII, Bharat Biotech yet | What we know

  India | December 30, 2020 23:15 IST

  The analysis of the additional data and information submitted by Serum Institute of India (SII) and Bharat Biotech is still being conducted by regulator Central Drug Standard Control Organisation's (CDSCO) Subject Expert Committee and their next meeting will be held on January 1.

• 

  How safe is Corona vaccine for people: The volunteers' story

  News | December 27, 2020 16:15 IST

  While no vaccine is truly a 100% side-effect free. Several volunteers, part of the COVID-19 vaccine trials speak to India TV about their experiences.

• 

  FACT CHECK: Serum Institute, Bharat Biotech's proposals for emergency use of COVID vaccine rejected?

  India | December 09, 2020 18:34 IST

  Amid a race to get the best COVID-19 vaccine, rumour mills are also abuzz with one speculation or the other. The Ministry of Health and Family Welfare today denied a report about the rejection of Serum Institute of India and Bharat Biotech's emergency-use authorisation of their respective vaccines. It said that the report was "fake".

Advertisement
• 

  Only India can satisfy world's Covid vaccine needs: Foreign envoys after Bharat Biotech tour

  India | December 09, 2020 18:18 IST

  Australian Ambassador to India Barry O'Farrell lauded the country's effort on development of a vaccine against coronavirus saying, "There're many vaccines being produced in countries around the world but there's only one country that has the manufacturing capacity to produce sufficient quantities to satisfy the demands of citizens in every country & that's India."

• 

  Serum Institute seeks emergency use nod for Covishield in India

  India | December 07, 2020 8:31 IST

  Covishield is logistically feasible for distribution in India's both urban and rural parts as it can be stored at two to eight degrees Celsius, which is an ideal temperature for being kept in cold storages in the country.

• 

  Adar Poonawalla of Serum Institute of India among 6 ‘Asians of the Year’ named by Singapore daily

  Business | December 05, 2020 10:17 IST

  Pune-based Serum Institute of India (SII) has collaborated with the University of Oxford and the British-Swedish pharmaceutical company AstraZeneca for making the Covid-19 vaccine, ‘‘Covidshield’‘, and is conducting trials in India.

• 

  Covishield safe and immunogenic, incident with Chennai volunteer no way induced by it: SII

  India | December 01, 2020 14:00 IST

  Vaccine major Serum Institute of India on Tuesday rejected charges that a COVID-19 vaccine candidate 'Covidshield' has serious side effects, adding that the incident with the Chennai volunteer is no way induced by the vaccine.

• 

  Coronavirus vaccine: Serum Institute to apply for emergency authorisation of Covishield in next 2 weeks

  News | November 28, 2020 20:08 IST

  After holding a review meeting with Prime Minister Narendra Modi on Saturday, Serum Institute of India CEO Adar Poonawalla said that in the process of applying for emergency use authorization of Covishield in the next two weeks.

• 

  In process of applying for emergency use authorization of Covishield in next 2 weeks: SII CEO

  India | November 28, 2020 20:13 IST

  After holding a review meeting with Prime Minister Narendra Modi on Saturday, Serum Institute of India CEO Adar Poonawalla said that in the process of applying for emergency use authorization of Covishield in the next two weeks.

• 

  PM Modi undertakes whirlwind 3-city tour to take stock of vaccine development

  India | November 28, 2020 23:15 IST

  Prime Minister Narendra Modi on Saturday reviewed coronavirus vaccine development process across various centres in the country. PM Modi visited three vaccine development hubs including Zydus Cadila's plant in Ahmedabad, Bharat Biotech which is working on India's own vaccine named Covaxin in Hyderabad and Serum Institute of India in Pune.

• 

  Maharashtra: CM Uddhav Thackeray, Governor not to accompany PM Modi during his SII visit in Pune

  India | November 28, 2020 13:28 IST

  Modi began his three-city visit on Saturday to review coronavirus vaccine development work by going to pharma major Zydus Cadila''s manufacturing facility near Ahmedabad in the morning.

• 

  PM Modi visits Bharat Biotech facility in Hyderabad to review COVID vaccine development

  India | November 28, 2020 15:08 IST

  The PM will be flying back to the national capital after a stopover in Pune, where he will visit the Serum Institute of India (SII), which has partnered with pharma giant AstraZeneca and the Oxford University for the vaccine. Earlier in the morning, Modi visited Zydus Cadila''s plant near Ahmedabad.